In
A 1997 study in Health Policy found that whereas the average wait time for bypass surgery in
In
This is the reality in government-run health care systems, as they focus more on saving money than on saving lives. That’s why citizens experience long wait times, a lack of access to certain treatments, and substandard medical care.
Consider this new op-ed from Mark Henderson, Science Editor of The (
First consider the title: "We need cancer drug rationing."
And then some selected paragraphs:
“Rationing is never a popular exercise, and never more so than in medicine. The idea that the NHS is universal and free has become so deeply ingrained that nobody is happy when it denies treatments on grounds of expense.”
“As knowledge of the molecular and genetic mechanisms of disease increases, this situation is likely to worsen. More and more treatments will become available. Some will be personalised for a small group of patients and will thus be expensive because the market is limited. Others may extend life only for a short period and will offer poor value for money on the NICE model. Some will have to be rejected for NHS use, even though they work.”
“At present, this means in practice that most patients are refused them altogether.”
And now over to the other Times, the New York Times -- America's "newspaper of record."
In his August 11th column,
It sure hasn’t been easy for the countries that have tried.